A molecular and preclinical comparison of the PD-1–targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference37 articles.
1. PD-1 and its ligands in tolerance and immunity;Keir;Annu Rev Immunol,2008
2. B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells;Azuma;Blood,2008
3. Engagement of the Pd-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation;Freeman;J Exp Med,2000
4. B7-H1 up-regulated expression in human pancreatic carcinoma tissue associates with tumor progression;Geng;J Cancer Res Clin Oncol,2008
5. B7-H1 expression associates with tumor invasion and predicts patient’s survival in human esophageal cancer;Chen;Int J Clin Exp Pathol,2014
Cited by 201 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging molecular therapies in the treatment of bladder cancer;Exploration of Targeted Anti-tumor Therapy;2024-08-29
2. Immunomodulatory Synthetic Glycocluster Molecule Prevents Melanoma Growth In Vivo;ChemBioChem;2024-08-26
3. Influence of the Immune Checkpoint Inhibitors on the Hemostatic Potential of Blood Plasma;Transfusion Medicine and Hemotherapy;2024-08-21
4. Population Pharmacokinetics and Exposure‐Response Relationship of Zimberelimab in Chinese Patients with Advanced Tumors;Clinical Pharmacology in Drug Development;2024-07-15
5. Retrospective cohort study characterizing PD-1/PD-L1 checkpoint inhibition associated Stevens-Johnson syndrome and toxic epidermal necrolysis;Journal of the American Academy of Dermatology;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3